ArticleCancer2024

Should patients with hormone receptor-positive, HER2-negative breast cancer and one or two positive sentinel nodes undergo axillary dissection to determine candidacy for adjuvant abemaciclib?

Austin D Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.